Observational Study of Lamotrigine
NCT00299793 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2007-03-23
Summary
The purpose of this study is to assess efficacy, safety and tolerability of lamotrigine as used in a natural clinical setting, to examine the positive effects of lamotrigine, and the reasons why some patients choose to continue or discontinue lamotrigine.
Conditions
Sponsors & Collaborators
- collaborator INDUSTRY
-
Northwell Health
lead OTHER
Principal Investigators
-
Alan Ettinger, MD · Northwell Health
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2001-10-31
Countries
- United States
Study Locations
More Related Trials
-
A Study of the Safety of Topiramate Given in Combination With Other Medications in Adults and Children With Seizures
NCT00297349 ·Status: COMPLETED
-
Clinical Study of Lamotrigine to Treat Newly Diagnosed Epilepsy
NCT01431963 ·Status: COMPLETED ·Phase: PHASE3
-
Open-Label Extension Study to Assess the Safety and Seizure Frequency Associated With Lacosamide for Primary Generalized Tonic-Clonic Seizures in Subjects With Epilepsy
NCT01118962 ·Status: COMPLETED ·Phase: PHASE2
-
Research Study to Test Safety and Effectiveness of Investigational Drug in Patients With Trigeminal Neuralgia
NCT00203229 ·Status: COMPLETED ·Phase: NA
-
Measurement Of Serum Levels Of Two Antiepileptic Drugs During Conversion In Patients With Epilepsy
NCT00043914 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Look at Antiepileptic Drug Levels While on Lamictal or Depakote With or Without an Oral Contraceptive
NCT00296413 ·Status: COMPLETED
-
Special Drug Use Investigation for LAMICTAL® (Long Term)
NCT01863602 ·Status: COMPLETED
-
Treatment Of Primary Generalized Tonic-Clonic Seizures With An Investigational New Drug
NCT00043901 ·Status: COMPLETED ·Phase: PHASE4
-
Patients With Epilepsy Taking LAMICTAL Immediate-Release Who Switch To Extended-Release Formulation And Vice Versa
NCT00264615 ·Status: COMPLETED ·Phase: PHASE3
-
WEUKBRE5557: IMI PROTECT(Work Package 2): Antiepileptics & Suicide
NCT01607333 ·Status: COMPLETED
-
Bioequivalence and Food Effect of 250mg of Lamotrigine XR
NCT00605371 ·Status: COMPLETED ·Phase: PHASE1
-
Pediatric Epilepsy Study in Subjects 1-24 Months
NCT00044278 ·Status: COMPLETED ·Phase: PHASE2
-
An Observational Study of Epilepsy: Biology and Outcomes Using Real-world Data
NCT05632978 ·Status: RECRUITING
-
Effect of Adding Lamotrigine to Sodium Valproate in Childhood Epilepsy: Clinicolabratory Study
NCT05881928 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Lamotrigine and Oral Contraceptives
NCT00266149 ·Status: TERMINATED ·Phase: PHASE3
-
Lamictal in the Treatment of Post-Herpetic Neuralgia
NCT00295776 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Precision Medicine in the Treatment of Epilepsy
NCT05450822 ·Status: RECRUITING
-
Hormone Profiles in Adults With Newly Diagnosed Epilepsy
NCT00137709 ·Status: UNKNOWN ·Phase: PHASE4
-
WEUSKOP6166: Lamotrigine and Aseptic Meningitis
NCT01657864 ·Status: COMPLETED
-
The Effect of a Single Dose of Lamotrigine on Brain Function in Healthy Volunteers
NCT04396938 ·Status: COMPLETED ·Phase: NA
-
Lamotrigine Cognitive Function Study in Adult Untreated Epilepsies
NCT00896987 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
NCT01529034 ·Status: TERMINATED ·Phase: PHASE3
-
Bioequivalence And Lack Of Food Effects Of 300mg Lamotrigine XR
NCT00412191 ·Status: COMPLETED ·Phase: PHASE1
-
Human Epilepsy Project 3
NCT05374928 ·Status: ACTIVE_NOT_RECRUITING
-
An Open-Label Extension Study to Evaluate the Safety and Effectiveness of RWJ 333369 in Patients With Epilepsy
NCT00210652 ·Status: COMPLETED ·Phase: PHASE2